Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 770

Results For "IT"

10355 News Found

ProBioGen’s growth strategy continues successfully
News | March 03, 2023

ProBioGen’s growth strategy continues successfully

Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team


Zydus receives final approval from the USFDA for Acyclovir Cream
Drug Approval | March 03, 2023

Zydus receives final approval from the USFDA for Acyclovir Cream

he product will be launched shortly in the US market.


Department of Pharmaceuticals to celebrate 5th Jan Aushadhi Diwas on March 7
News | March 01, 2023

Department of Pharmaceuticals to celebrate 5th Jan Aushadhi Diwas on March 7

Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana


5 crore health records of individuals linked to their ABHA for anytime access
Policy | March 01, 2023

5 crore health records of individuals linked to their ABHA for anytime access

With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)


Zydus receives final approval from the USFDA for Apixaban Tablets
Drug Approval | March 01, 2023

Zydus receives final approval from the USFDA for Apixaban Tablets

Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).


Vaishali Pharma receives multiple orders worth US$ 73.85 million
News | March 01, 2023

Vaishali Pharma receives multiple orders worth US$ 73.85 million

This order is subject to initial advance payment as per the agreed terms of the contract


Ayush Minister inaugurates first Chintan Shivir
News | March 01, 2023

Ayush Minister inaugurates first Chintan Shivir

Sonowal exhorted young researchers and scientist to work on evidence based scientific research


Dr. Reddy's Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolio
News | March 01, 2023

Dr. Reddy's Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolio

The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.


Zydus receives final approval from the USFDA for Hydrochlorothiazide Tablets
Drug Approval | March 01, 2023

Zydus receives final approval from the USFDA for Hydrochlorothiazide Tablets

This combination medicine is used to treat high blood pressure (hypertension).


NATCO launches generic Pomalidomide Capsules in Canada
News | March 01, 2023

NATCO launches generic Pomalidomide Capsules in Canada

Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules